Sunday, July 20, 2014

The Motley Fool: AbbVie Inc. Wins the Shire

Pfizer couldn't bag AstraZeneca and Valeant is still trying win over Allergan's (NYSE: AGN  ) shareholders, but AbbVie (NYSE: ABBV  ) has managed to close its major deal. AbbVie and Shire (SHPG) announced on Friday that the companies had agreed to a merger that will see AbbVie acquire the Irish-based drugmaker on the previously announced terms of GBP 24.44 cash and 0.896 shares of AbbVie for each Shire share.

Read the full article here:
AbbVie Inc. Wins the Shire

No comments: